Sort
11,323 grants matching “glioblastoma”
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
$495,171Daniel J Brat · Northwestern University At Chicago · R01 · FY2023 · CA
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
$495,169Daniel J Brat · Northwestern University At Chicago · R01 · FY2022 · CA
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
$494,886Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
$494,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Translational Immunology
$494,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Rare Central Nervous System Cancers Initiative
$494,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Optimization of ultrasound-mediated drug delivery to the brain under clinically relevant conditions
$494,505Nathan J McDannold · Brigham And Women'S Hospital · R01 · FY2025 · EB
Optimization of ultrasound-mediated drug delivery to the brain under clinically relevant conditions
$494,505Nathan J McDannold · Brigham And Women'S Hospital · R01 · FY2023 · EB
Validation of imaging brain tumor metabolism using deuterated glucose
$494,260Henk De Feyter · Yale University · R01 · FY2023 · EB
Magnetic-vortex microdiscs for glioma therapy
$494,193Maciej S Lesniak · University Of Chicago · R01 · FY2015 · NS
Effect of Bone Marrow Cells on the Radiosensitivity of Brain and Mouth Cancers
$494,069John Martin Brown · Stanford University · R01 · FY2012 · CA
Role of meningeal lymphatic vasculature in neuroimmune communication development
$494,067Jean-Leon Thomas · Yale University · R01 · FY2025 · NS
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$493,987Darell D Bigner · Duke University · P01 · FY2020 · CA
Project 1: Inhibition of Metastasis Utilizing Pharmacological Ascorbate in Pancreas Cancer
$493,783Joseph J Cullen · University Of Iowa · P01 · FY2019 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2015 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2016 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2014 · CA
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
$493,574William F Elmquist · University Of Minnesota · R01 · FY2015 · NS
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$493,555Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$493,424Robert M Prins · University Of California Los Angeles · R01 · FY2025 · CA
Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors
$493,422William F Elmquist · University Of Minnesota · R01 · FY2016 · NS
Mechanisms of targeting cellular self-renewal in glioblastoma
$493,327Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$493,225Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
MRI fluorescence tomography for quantifying tumor receptor concentration in vivo
$492,912Scott C Davis · Dartmouth College · R01 · FY2016 · CA
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
$492,571Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2023 · CA